These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11423508)

  • 21. Glucose intolerance and risk of cardiovascular disease in Iranian men and women: results of the 7.6-year follow-up of the Tehran Lipid and Glucose Study (TLGS).
    Hadaegh F; Khalili D; Fahimfar N; Tohidi M; Eskandari F; Azizi F
    J Endocrinol Invest; 2009 Oct; 32(9):724-30. PubMed ID: 19574728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevalence of type II diabetes mellitus in population of Krakow].
    Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
    Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetes mellitus, impaired glucose tolerance, and hyperinsulinemia in an elderly population. The Rotterdam Study.
    Stolk RP; Pols HA; Lamberts SW; de Jong PT; Hofman A; Grobbee DE
    Am J Epidemiol; 1997 Jan; 145(1):24-32. PubMed ID: 8982019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population.
    Martínez-Larrad MT; Corbatón-Anchuelo A; Fernández-Pérez C; Lazcano-Redondo Y; Escobar-Jiménez F; Serrano-Ríos M
    Diabetes Res Clin Pract; 2016 Apr; 114():23-31. PubMed ID: 27103365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High risk of cardiovascular mortality in individuals with impaired fasting glucose is explained by conversion to diabetes: the Hoorn study.
    Rijkelijkhuizen JM; Nijpels G; Heine RJ; Bouter LM; Stehouwer CD; Dekker JM
    Diabetes Care; 2007 Feb; 30(2):332-6. PubMed ID: 17259503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III).
    Muntner P; He J; Chen J; Fonseca V; Whelton PK
    Ann Epidemiol; 2004 Oct; 14(9):686-95. PubMed ID: 15380800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
    Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
    PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of diabetes mellitus and impaired glucose metabolism in the adult population of the Basque Country, Spain.
    Aguayo A; Urrutia I; González-Frutos T; Martínez R; Martínez-Indart L; Castaño L; Gaztambide S;
    Diabet Med; 2017 May; 34(5):662-666. PubMed ID: 27353285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease.
    Targher G; Bertolini L; Padovani R; Poli F; Scala L; Tessari R; Zenari L; Falezza G
    Diabet Med; 2006 Apr; 23(4):403-9. PubMed ID: 16620269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of diabetes and impaired fasting glucose in Costa Rica: Costa Rican National Cardiovascular Risk Factors Survey, 2010.
    Wong-McClure R; Gregg EW; Barcelo A; Sanabria-Lopez L; Lee K; Abarca-Gomez L; Cervantes-Loaiza M; Luman ET
    J Diabetes; 2016 Sep; 8(5):686-92. PubMed ID: 26516694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cardiovascular disease in patients with type 1 and type 2 diabetes in Spain].
    Ortega E; Amor AJ; Rojo-Martínez G; Castell C; Giménez M; Conget I
    Med Clin (Barc); 2015 Sep; 145(6):233-8. PubMed ID: 25561182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India.
    Ramachandran A; Mary S; Yamuna A; Murugesan N; Snehalatha C
    Diabetes Care; 2008 May; 31(5):893-8. PubMed ID: 18310309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.
    Wild RA; Carmina E; Diamanti-Kandarakis E; Dokras A; Escobar-Morreale HF; Futterweit W; Lobo R; Norman RJ; Talbott E; Dumesic DA
    J Clin Endocrinol Metab; 2010 May; 95(5):2038-49. PubMed ID: 20375205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.
    Lorenzo C; Williams K; Hunt KJ; Haffner SM
    Diabetes Care; 2007 Jan; 30(1):8-13. PubMed ID: 17192325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum metabolomic profiles associated with subclinical and clinical cardiovascular phenotypes in people with type 2 diabetes.
    Huang Z; Klaric L; Krasauskaite J; McLachlan S; Strachan MWJ; Wilson JF; Price JF
    Cardiovasc Diabetol; 2022 Apr; 21(1):62. PubMed ID: 35477395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired fasting glucose is associated with increased severity of subclinical coronary artery disease compared to patients with diabetes and normal fasting glucose: evaluation by coronary computed tomographic angiography.
    Gurudevan S; Garg P; Malik S; Khattar R; Saremi F; Hecht H; DeMaria A; Narula J
    BMJ Open; 2016 Aug; 6(8):e005148. PubMed ID: 27531720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DISEASES OF CIRCULATORY SYSTEM AND COMORBID TYPE II DIABETES MELLITUS IN THE CHORNOBYL ACCIDENT CONSEQUENCES CLEAN-UP WORKERS.
    Bazyka OD; Bilyi DO
    Probl Radiac Med Radiobiol; 2018 Dec; 23():246-253. PubMed ID: 30582850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Undiagnosed dysglycaemia and inflammation in cardiovascular disease.
    Johansen OE; Birkeland KI; Brustad E; Aaser E; Lindahl AK; Midha R; Ueland T; Aukrust P; Gullestad L
    Eur J Clin Invest; 2006 Aug; 36(8):544-51. PubMed ID: 16893376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in comorbidity in patients hospitalised for cardiovascular disease.
    Buddeke J; Bots ML; van Dis I; Liem A; Visseren FLJ; Vaartjes I
    Int J Cardiol; 2017 Dec; 248():382-388. PubMed ID: 28712563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevalence of the glucose metabolism disturbances in screening of adult inhabitants of Krakow].
    Szurkowska M; Szafraniec K; Gilis-Januszewska A; Pach D; Krzentowska A; Szybiński Z; Huszno B
    Przegl Lek; 2006; 63(9):728-32. PubMed ID: 17479858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.